BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rodriguez S, Skeet K, Mehmetoglu-Gurbuz T, Goldfarb M, Karri S, Rocha J, Shahinian M, Yazadi A, Poudel S, Subramani R. Phytochemicals as an Alternative or Integrative Option, in Conjunction with Conventional Treatments for Hepatocellular Carcinoma. Cancers (Basel) 2021;13:5753. [PMID: 34830907 DOI: 10.3390/cancers13225753] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Gao S, Jiang X, Wang L, Jiang S, Luo H, Chen Y, Peng C. The pathogenesis of liver cancer and the therapeutic potential of bioactive substances. Front Pharmacol 2022;13:1029601. [DOI: 10.3389/fphar.2022.1029601] [Reference Citation Analysis]
2 Liu K, Sun Q, Liu Q, Li H, Zhang W, Sun C. Focus on immune checkpoint PD-1/PD-L1 pathway: New advances of polyphenol phytochemicals in tumor immunotherapy. Biomedicine & Pharmacotherapy 2022;154:113618. [DOI: 10.1016/j.biopha.2022.113618] [Reference Citation Analysis]
3 Yadav RP, Chatterjee S, Chatterjee A, Pal DK, Ghosh S, Acharya K, Das M. Identification of novel mycocompounds as inhibitors of PI3K/AKT/mTOR pathway against RCC. J Recept Signal Transduct Res 2022;:1-9. [PMID: 36125981 DOI: 10.1080/10799893.2022.2123515] [Reference Citation Analysis]
4 Wang HM, He JA, Wang JH. Development of a prognostic model for hepatocellular carcinoma based on ferroptosis-related long non-coding RNAs. Shijie Huaren Xiaohua Zazhi 2022; 30(14): 623-630 [DOI: 10.11569/wcjd.v30.i14.623] [Reference Citation Analysis]